The Application of Pyrrolo[2, 3-d]pyrimidine Scaffold in Medicinal Chemistry from 2017 to 2021

被引:3
作者
Liang, Ting [1 ]
Yang, Yingxiang [1 ]
Wang, Jiayun [1 ]
Xie, Zhao [1 ]
Chen, Xin [1 ]
机构
[1] Northwest A&F Univ, Coll Chem & Pharm, Shaanxi Key Labotory Nat Prod & Chem Biol, Yangling 712100, Peoples R China
基金
中国国家自然科学基金;
关键词
Pyrrolo[2; 3-d]pyrimidine; anti-inflammatory; IKKs; NIK; antibacterial; antitumor activities; KINASE; 2; LRRK2; T-CELL KINASE; THERAPEUTIC TARGET; BIOLOGICAL EVALUATION; SIGNALING PATHWAY; IN-VITRO; HIGHLY POTENT; KAPPA-B; INHIBITORS; DISCOVERY;
D O I
10.2174/1389557523666230111161810
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The application of privileged structures in drug design is an effective strategy, which usually leads to innovative hits/leads and successful structural optimization. Pyrrolo[2, 3-d]pyrimidine are such a scaffold which are frequently used in many clinical drugs. The biocompounds bearing pyrrolo[2, 3-d]pyrimidine skeleton show different pharmacological effects such as anti-neurodegenerative, anti-inflammatory, antibacterial, and antitumor activities. In this article, we reviewed the representative structures and biological characteristics of reported synthetic pyrrolo[2, 3-d]pyrimidine compounds from 2017 to 2021. The linked diseases and targets were also mentioned briefly. This work might provide a reference for the subsequent drug discovery based on pyrrolo[2, 3-d]pyrimidine scaffold.
引用
收藏
页码:1118 / 1136
页数:19
相关论文
共 150 条
  • [1] Identification of new pyrrolo [2,3-d]pyrimidines as potent VEGFR-2 tyrosine kinase inhibitors: Design, synthesis, biological evaluation and molecular modeling
    Adel, Mai
    Serya, Rabah A. T.
    Lasheen, Deena S.
    Abouzid, Khaled A. M.
    [J]. BIOORGANIC CHEMISTRY, 2018, 81 : 612 - 629
  • [2] A mini-review of c-Met as a potential therapeutic target in melanoma
    Al-U'datt, Doa'a G. F.
    Al-Husein, Belal A. A.
    Qasaimeh, Ghazi Raji
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2017, 88 : 194 - 202
  • [3] Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX
    Alterio, Vincenzo
    Hilvo, Mika
    Di Fiore, Anna
    Supuran, Claudiu T.
    Pan, Peiwen
    Parkkila, Seppo
    Scaloni, Andrea
    Pastorek, Jaromir
    Pastorekova, Silvia
    Pedone, Carlo
    Scozzafava, Andrea
    Monti, Simona Maria
    De Simone, Giuseppina
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (38) : 16233 - 16238
  • [4] T-Cell Signaling Regulated by the Tec Family Kinase, Itk
    Andreotti, Amy H.
    Schwartzberg, Pamela L.
    Joseph, Raji E.
    Berg, Leslie J.
    [J]. COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2010, 2 (07): : a002287
  • [5] Inhibitory Kappa B Kinase α (IKKα) Inhibitors That Recapitulate Their Selectivity in Cells against Isoform-Related Biomarkers
    Anthony, Nahoum G.
    Baiget, Jessica
    Berretta, Giacomo
    Boyd, Marie
    Breen, David
    Edwards, Joanne
    Gamble, Carly
    Gray, Alexander I.
    Harvey, Alan L.
    Hatziieremia, Sophia
    Ho, Ka Ho
    Huggan, Judith K.
    Lang, Stuart
    Llona-Minguez, Sabin
    Luo, Jia Lin
    McIntosh, Kathryn
    Paul, Andrew
    Plevin, Robin J.
    Robertson, Murray N.
    Scott, Rebecca
    Suckling, Colin J.
    Sutcliffe, Oliver B.
    Young, Louise C.
    Mackay, Simon P.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (16) : 7043 - 7066
  • [6] AXL-Driven EMT State as a Targetable Conduit in Cancer
    Antony, Jane
    Huang, Ruby Yun-Ju
    [J]. CANCER RESEARCH, 2017, 77 (14) : 3725 - 3732
  • [7] Cell cycle regulation and anticancer drug discovery
    Bai, Jingwen
    Li, Yaochen
    Zhang, Guojun
    [J]. CANCER BIOLOGY & MEDICINE, 2017, 14 (04) : 348 - 362
  • [8] Targeting FAK scaffold functions inhibits human renal cell carcinoma growth
    Beraud, Claire
    Dormoy, Valerian
    Danilin, Sabrina
    Lindner, Veronique
    Bethry, Audrey
    Hochane, Mazene
    Coquard, Catherine
    Barthelmebs, Mariette
    Jacqmin, Didier
    Lang, Herve
    Massfelder, Thierry
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2015, 137 (07) : 1549 - 1559
  • [9] PURINE METABOLISM IN TRYPANOSOMA-CRUZI
    BERENS, RL
    MARR, JJ
    LAFON, SW
    NELSON, DJ
    [J]. MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 1981, 3 (03) : 187 - 196
  • [10] Structure-activity study leading to identification of a highly active thienopyrimidine based EGFR inhibitor
    Bugge, Steffen
    Kaspersen, Svein Jacob
    Larsen, Synne
    Nonstad, Unni
    Bjorkoy, Geir
    Sundby, Eirik
    Hoff, Bard Helge
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2014, 75 : 354 - 374